GENNEX LABORATORIES
|
The Current P/E Ratio of GENNEX LABORATORIES is 14.84.
Share Price | ₹12.8 | Mar 10,2025 |
Market Cap | ₹290.6 Cr | |
Earnings-TTM | ₹19.6 Cr | TTM-Consolidated Results |
Price/Earnings | 14.84x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of GENNEX LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹290.6 Cr] as on Mar 10,2025
(/) Earnings [ ₹19.6 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 14.84x ]
Thus, for GENNEX LABORATORIES , the investors are currently willing to pay 14.84 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GENNEX LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of GENNEX LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of GENNEX LABORATORIES
PE Ratio Performance Analysis for GENNEX LABORATORIES
- GENNEX LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 18.71x.
- GENNEX LABORATORIES 's operated at median p/e ratio of 16x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GENNEX LABORATORIES 's p/e ratio peaked in Mar2024 at 31.6x.
- GENNEX LABORATORIES 's p/e ratio hit its five-year low in Mar2021 of 11.69x.
How does GENNEX LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
GENNEX LABORATORIES | 19.59 | 14.84 | 290.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 33.66 | 386,569.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 70.79 | 146,318.0 |
CIPLA LTD | 5,000.43 | 23.62 | 118,110.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 55.81 | 103,926.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.22 | 93,471.5 |
MANKIND PHARMA LTD | 2,050.73 | 45.48 | 93,257.2 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.57 | 89,876.8 |
LUPIN LTD | 2,892.10 | 31.72 | 91,732.8 |
AUROBINDO PHARMA LTD | 3,500.25 | 18.13 | 63,472.9 |
ABBOTT INDIA LTD | 1,334.46 | 48.78 | 65,100.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GENNEX LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 14.84x |
Max industry PE | 70.79x |
Median industry PE | 31.72x |
Average industry PE | 34.51x |
You may also like the below Video Courses